
Journal of Organometallic Chemistry p. 691 - 695 (2005)
Update date:2022-07-30
Topics:
Laus, Gerhard
Schottenberger, Herwig
Lukasser, Josef
Wurst, Klaus
Schütz, Johannes
Ongania, Karl-Hans
Zsolnai, László
Treatment of 1,4-diferrocenyl-1,3-butadiyne dicobalt hexacarbonyl complex (1) [CARN: 178388-65-3] with trifluoroacetic acid resulted in cyclisation with concomitant CO insertion to give the green 2,3-ferroceno-7-ferrocenyl-4,5- dehydrotropone dicobalt hexacarbonyl (2), which in turn was converted by trifluoroacetic acid to red 2,3-ferroceno-7-ferrocenyltropone (3). The first step implied the involvement of a second dicobalt hexacarbonyl complex as a CO source. The molecular structures of 2 and 3 were determined by single crystal X-ray analysis, and pairs of enantiomers with different conformations were observed in 3.
Dalian Join King Biochemical Tech. Co., Ltd.
Contact:0411 39216206
Address:814 First State Blvd
Tianjin Pharmacn Medical Technology Co.,Ltd.
Contact:86-22-60122566ext.866(English),23359620
Address:Green Industrial Base, 6 Haitaifazhan Sixth Rd., Huayuan Industrial Area, Tianjin, 300384, China
Zhejiang Golden-Shell Pharmaceutical Co.,Ltd.
Contact:+86-576-87501888 / 87501988
Address:No.89 Zhongxing Road. Li'ao, Yuhuan, Zhejiang, China
website:http://www.biet.com.cn/
Contact:+86-27-8369 8488
Address:No. 6, Building 21, China Merchants Fanwang, Sixin North Road, Hanyang District, Wuhan City, Hubei Province
Xi'an Costrong Pharmaceutical Co., Ltd.
Contact:029- 68576496
Address:Room 2004,Shuibao Building,No.190,South Erhuan Rd, Yanta District,Xi'an,Shaan Xi,China
Doi:10.1016/S0957-4166(02)00105-2
(2002)Doi:10.1021/ja027346p
(2002)Doi:10.1016/j.ejmech.2021.113224
(2021)Doi:10.1016/j.bmcl.2016.05.025
(2016)Doi:10.1002/jhet.5570390213
(2002)Doi:10.1055/s-1987-28197
(1987)